FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
06/18/2026
Back to search
Official data from USPTO
HYDIFFUZE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
HYDIFFUZE
ST13
US500000079405666Class
5, 42
Filing
79405666
Registration
8045176
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
32
Latest update
06/19/2026
Trademark type
Word
Nice classes
5, 42
Filing date
08/19/2024
Registration date
12/02/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/02/2025
Last transaction
06/19/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
03
Owner location
KR
Examiner
RUIZ SANTIAGO, REBECCA E
Law office
O30
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
HuonsLab Co., Ltd.
Representatives
James R Menker Holley & Menker, PA
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Vaccines; enzymes for veterinary purposes; ferments for pharmaceutical purposes; pharmaceutical agents for epidermis; cellular function activating agents for medical purposes; medicinal creams for skin care; enzymes for medical purposes; enzyme preparations for medical purposes; medicines for human purposesinjectable medication containing hyaluronidase for the treatment of cancerauto-immune diseasesneurological disorders and chronic pain; enzyme preparations for medical purposes containing recombinant human hyaluronidase as an active ingredient; enzymes for medical purposes containing recombinant human hyaluronidase; medicated skin care preparations
Class 42
Research and development of siRNA drugs; scientific research; research and development of vaccines and medicines; biomedical research services; drug discovery services; pharmaceutical drug development services; development of pharmaceutical preparations and medicines; pharmaceutical research services; research on the subject of pharmaceuticals; development of gene-based medicines; technical research in the field of pharmaceutical studies; testing of pharmaceuticals; consultancy in the field of testinginspectionresearch of medical products; medical research services
Publications
History of USPTO decisions and trademark events.
32 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
06/01/2026
FIMP
FINAL DISPOSITION PROCESSED
06/01/2026
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
03/19/2026
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
03/02/2026
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
03/02/2026
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
03/02/2026
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/02/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
12/02/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/14/2025
PUBO
PUBLISHED FOR OPPOSITION
10/14/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/08/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/16/2025
XAEC
EXAMINER'S AMENDMENT ENTERED
09/16/2025
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
09/16/2025
GNEA
EXAMINERS AMENDMENT E-MAILED
09/16/2025
CNEA
EXAMINERS AMENDMENT -WRITTEN
09/16/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/04/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/04/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/04/2025
RFNT
REFUSAL PROCESSED BY IB
05/04/2025
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
04/15/2025
RFRR
REFUSAL PROCESSED BY MPU
04/14/2025
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/08/2025
CNRT
NON-FINAL ACTION WRITTEN
03/07/2025
RFWR
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
03/07/2025
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/07/2025
CNRT
NON-FINAL ACTION WRITTEN
03/06/2025
DOCK
ASSIGNED TO EXAMINER
02/24/2025
MAFR
APPLICATION FILING RECEIPT MAILED
10/16/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/16/2024
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
10/03/2024
Continuous trademark protection
Get notified about every new filing that threatens HYDIFFUZE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.